Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
Clinical trial NCT03658031 · UNKNOWN
Trial details
- NCT number
- NCT03658031
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2020-12-31
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.